AmerisourceBergen Corporation – Consensus Indicates Potential 22.1% Upside
AmerisourceBergen Corporation with ticker code (ABC) now have 12 analysts covering the stock with the consensus suggesting a rating of ''Buy''. The range between the high target price and low target price is between 187 and 155 with a mean TP of 171.92. Now with the previous closing price of 140.79 this indicates there is a potential upside of 22.1%. The 50 day MA is 149.17 and the 200 day MA is 138.45. The company has a market capitalisation of $29,859m. Company Website: https:||www.amerisourcebergen.com [stock_market_widget type="chart" template="basic" color="green" assets="ABC" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $36,461m based on the market concensus. AmerisourceBergen Corporation sources and distributes pharmaceutical products in the United States and internationally. Its Pharmaceutical Distribution segment distributes brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to various healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers.
AmerisourceBergen Corporation – Consensus Indicates Potential 22.1% Upside
AmerisourceBergen Corporation with ticker code (ABC) now have 12 analysts covering the stock with the consensus suggesting a rating of ''Buy''. The range between the high target price and low target price is between 187 and 155 with a mean TP of 171.92. Now with the previous closing price of 140.79 this indicates there is a potential upside of 22.1%. The 50 day MA is 149.17 and the 200 day MA is 138.45. The company has a market capitalisation of $29,859m. Company Website: https:||www.amerisourcebergen.com [stock_market_widget type="chart" template="basic" color="green" assets="ABC" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $36,461m based on the market concensus. AmerisourceBergen Corporation sources and distributes pharmaceutical products in the United States and internationally. Its Pharmaceutical Distribution segment distributes brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to various healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers.